• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - COSTA RICA (COYOL) LUGE GUIDE WIRE; WIRE, GUIDE, CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - COSTA RICA (COYOL) LUGE GUIDE WIRE; WIRE, GUIDE, CATHETER Back to Search Results
Model Number UNK496
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Chest Pain (1776)
Event Date 12/17/2010
Event Type  Injury  
Event Description
(b)(6) clinical study.It was reported that chest pain occurred.On unspecified date, the patient was diagnosed with stable angina and cardiac catheterization was recommended.Subsequently, coronary angiography and the index procedure were performed.The target lesion was a de novo lesion located in the distal left circumflex (lcx) with 80% stenosis and was 15mm long with a reference vessel diameter of 2.5 mm.The lesion was treated with direct stent placement using a 2.50 mm x 2mm taxus® liberté® stent.Following post dilatation, residual stenosis was 0%.The target lesion #2 was a de novo lesion located in the 1st obtuse marginal (om) with 95% stenosis and was 15mm long with a reference vessel diameter of 3.5 mm.The target lesion #2 was pre-dilated with the balloon of the 2.5 x 28mm stent followed by placement of a 3.50 x 24 mm taxus® liberté® stent.Following post dilatation, residual stenosis was 0%.The target lesion #3 was a de novo lesion located in mid left anterior descending (lad) artery with 99% stenosis and was 12 mm long with a reference vessel diameter of 2.5 mm.A 182 cm luge guide wire was crossed in the lesion.However, the patient was noted to have chest pain which was treated with 50 mcg of fentanyl.The lesion was then treated with pre-dilation and placement of a 2.50 x 16mm taxus® liberté® stent.Following post dilatation, residual stenosis 0%.One day post procedure, the patient was discharged on aspirin and prasugrel.
 
Manufacturer Narrative
Device evaluated by mfr.: it is indicated that the device will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUGE GUIDE WIRE
Type of Device
WIRE, GUIDE, CATHETER
Manufacturer (Section D)
BOSTON SCIENTIFIC - COSTA RICA (COYOL)
2546 first street
propark free zone
alajuela
CS 
Manufacturer (Section G)
BOSTON SCIENTIFIC - COSTA RICA (COYOL)
2546 first street
propark free zone
alajuela
CS  
Manufacturer Contact
ingrid matte
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4106993
MDR Text Key4699975
Report Number2134265-2014-05602
Device Sequence Number1
Product Code DQX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K973945
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/28/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUNK496
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/28/2014
Initial Date FDA Received09/22/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age72 YR
-
-